Garwin Gerstein & Fisher LLP and its predecessor firms have successfully championed the rights 
of investors and consumers for over fifty years. Garwin Gerstein & Fisher are well known 
around the United States for skill in representing investors, consumers, small businesses and
the public in complex class action litigation involving such issues as:

     Antitrust violations, such as price-fixing and other anti-competitive practices. As a  
     result of our expertise, the settlements for our antitrust class members have frequently  
     ranged from 75% to 105%+ of single damages. Some of the firm's notable recent antitrust   
     sucesses include:

          * In re Buspirone Antitrust Litigation (S.D.N.Y.), settled in 2003 for $220 million 
          for a class of buspirone direct purchasers;  

          * In re Relafen Antitrust Litigation, (D. Mass.), settled in 2004 for $175 million 
          for a class of wholesalers that were Relafen direct purchasers; 

          * In re Cardizem CD Antitrust Litigation (E.D. Mich.), settled in 2002 for $110 
          million for a class of wholesalers that were diltiazem direct purchasers;

          * In re Terazosin Hydrochloride Antitrust Litigation (S.D.Fla.), settled in 2005 
          for $75 million for a class of Terazosin Hydrochloride direct purchasers;

          * In re Remeron Antitrust Litigation, (D.N.J.) settled in 2005 for $75 million 
          for a class of mirtazapine direct purchasers;

     In addition to the cases above, the firm is currently in charge of actively litigating 
     various other antitrust cases in the pharmaceutical, medical device, agricultural and 
     various other industries. 

     The violation of investors' rights due to securities fraud or breaches of fiduciary   
     duty. Garwin Gerstein & Fisher has been general or trial counsel for over fifty years
     in shareholder lawsuits that have not only established new Delaware precedents, but 
     also obtained substantial recoveries for our clients.
 
     A detailed description of some our seminal, landmark shareholder cases. Some of 
     the firm's recent successes, include:
     

          * Sanders v. Wang, etc., Del. Ch., CA No. 16640, Steele, V.C. (November 8, 1999);
          (Co-Lead Counsel) -- recovering $250 million in stock from Computer Associate 
          senior executives that allegedly exceeded their authority by improperly awarding  
          themselves excess shares pursuant to a stock option plan;

          * In re M&F Worldwide Corp. Shareholder Litigation, Consolidated Civil Action No. 
          18502, V.C. Strine, (Co-Trial Counsel) -- involved in a two week trial that   
          benefitted M&F shareholders by rescinding a series of improper transactions 
          valued at over $130 million.

          * Gutter v. E.I. DuPont de Nemours, et al., Case No. 95-2152 (S.D. Fla.), (Lead 
          Counsel) -- recovering $77.5 million in cash for Dupont shareholders that were 
          allegedly caused to overpay for Dupont stock due to allegedly false and misleading  
          statements. See e.g.,124 F.Supp.2d 1291 (S.D.Fla. 2000)

          * In re Cendant Corporation Derivative Action Litigation, 189 F.R.D. 117 (D.N.J. 
          1999), 232 F.Supp.2d 327 (D.N.J. 2002), (Lead Counsel) recovered $54,000,000 
          for Cendant, and its shareholders, from directors that allegedly breached their  
          fiduciary duties.

          * In Re Revlon Group, Inc. Shareholders Litigation (Del. Ch. Ct.), recovering $60 
          Million for Revlon sharedholders.

     Some of GGF's Other Notable Successes in protecting investors rights:

     Employment discrimination practices. 

     Garwin Gerstein & Fisher LLP has a thriving and growing employment practice, which is 
     litigating numerous employment discrimination class action, including such cases as 
     Employees Committed For Justice v. Eastman Kodak Company; Tim Jones and Janice Hardy 
     v. Eastman Kodak Company and Practice Works, Inc.; Cook et al. v. UBS Financial Services, 
     Inc.; Gaston et al. v. Exelon Corp., and various other cases. The firm’s employment 
     practice also includes collective actions brought on behalf of plaintiffs under the 
     federal and state laws governing overtime.

     Unfair and deceptive trade and insurance practices; 

          * Vadino, et al. v. American Home Products (Diet Drug Case Code #240; Superior 
          Court of New Jersey) senior member of legal team that recovered over $4 billion 
          in benefits on behalf of consumers of the diet drugs fenfluramine (Pondimin) and 
          dexfenfluramine (Redux).